Thomas J Knobloch, MS, PhD

Research Interest

>Cancer ● Carcinoma, Squamous Cell ● Mouth Cancer ● Loss of Heterozygosity ● Microsatellite Instability ● Leukoplakia

Thomas Knobloch, MS, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on molecular carcinogenesis and its interaction with food-based, cancer risk reduction strategies.

In particular, his work follows a bench-to-bedside, crop-to-clinic and food-to-pharma philosophy. He seeks to define translationally relevant molecular profiles in oral carcinogenic progression that advance food-based intervention strategies.

One of his recent studies confirmed that antiapoptotic and proinflammatory biomarkers may represent emerging biomarkers for molecular efficacy in black raspberry-mediated oral cancer chemoprevention.

Dr. Knobloch has co-authored many articles in well-respected publications, including International Journal of Cancer, Molecular Carcinogenesis and Cancer Immunology, Immunotherapy.